T Scientific Co., Ltd. (057680) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for T Scientific Co., Ltd. (057680:KRX), powered by AI.

Current Price
₩2,120
P/E Ratio
-23.6
Market Cap
30.2B
Sector
Common Stock
What is the T Scientific Co., Ltd. stock price forecast?

T Scientific Co., Ltd. is currently trading at ₩2,120. View real-time AI analysis on Alpha Lenz.

What is T Scientific Co., Ltd. insider trading activity?

View the latest insider trading data for T Scientific Co., Ltd. on Alpha Lenz.

What is T Scientific Co., Ltd.'s P/E ratio?

T Scientific Co., Ltd.'s P/E ratio is -23.6.

T Scientific Co., Ltd.

KRX · 057680
₩2,120-5(-0.24%)Market closedKRX regular session 09:00–15:30 KST
Ask about T Scientific Co., Ltd.'s future dividend policy...
Alpha Chat Insight

T Scientific Co., Ltd. trades at a P/E of -23.6 (undervalued) with modest ROE of -0.8%. 3Y revenue CAGR of 61.1% highlights clear growth momentum.

Ask for details

Company Overview

T Scientific Co., Ltd. is a dynamic entity in the biotechnology industry, specializing in the development and provision of innovative scientific solutions. Its primary focus is on creating cutting-edge medical and healthcare products, which play a crucial role in advancing both scientific research and clinical practices. By leveraging advanced technologies, T Scientific Co., Ltd. contributes significantly to the pharmaceutical and biotechnology sectors, enabling groundbreaking research and development opportunities. With a robust portfolio that includes research chemicals, reagents, and laboratory equipment, the company aids academic institutions, laboratories, and healthcare facilities in enhancing their scientific and medical endeavors. T Scientific Co., Ltd. operates within a highly regulated industry, ensuring compliance with stringent standards that safeguard product quality and efficacy. Globally recognized for its commitment to innovation and excellence, T Scientific Co., Ltd. plays a pivotal role in the biotechnological landscape, fostering advancements that impact not only the healthcare industry but also broader scientific communities. Its contributions support ongoing efforts to improve health outcomes and address complex medical challenges through scientific progress.

CEO김상우,유승재(각자대표)
SectorCommon Stock
IndustryCommon Stock
0

Company Statistics

FY 2025

Profile

₩30,209,364,000Market Cap
₩36,366,454,990Revenue
14.25MShares Out
0Employees

Margins

30.42%Gross
0.19%EBITDA
0.73%Operating
-13.33%Pre-Tax
-4.40%Net

Valuation

-23.59P/E
0.18P/B
0.83EV/Sales
336.83EV/EBITDA
48.54P/FCF

Growth (CAGR)

61.12%Rev 3Yr
30.74%Rev 5Yr
N/AOp Inc 3Yr
-18.34%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-0.88%ROA
-0.82%ROE
-2.23%ROIC

Financial Health

₩12,358,215,470Cash & Cash Equivalents
₩20,024,048,390Net Debt
19.17%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

T Scientific Co., Ltd. (ticker: 057680) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $30.2B.

The current price is ₩2,120 with a P/E ratio of -23.59x and P/B of 0.18x.

ROE is -0.82% and operating margin is 0.73%. Annual revenue is $36.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
T Scientific Co., Ltd. (057680) Stock Forecast 2026 ₩2,120 — Price, Financials & Analyst Targets | Alpha Lenz